The efficacy and safety of concurrent chemoradiotherapy for maxillary sinus squamous cell carcinoma patients

Auris Nasus Larynx

Volumn 36, Issue 5, 2009, Pages 547-554

  Nishimura, Goshi ^a   Tsukuda, Mamoru ^a   Mikami, Yasukazu ^a   Matsuda, Hideki ^a   Horiuchi, Choichi ^b   Satake, Kenichi ^b   Taguchi, Takahide ^b   Takahashi, Masahiro ^b   Kawakami, Mariko ^b   Hanamura, Hideaki ^b   Watanabe, Makiko ^b   Utsumi, Ai ^b  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Chemoradiotherapy; Chemotherapy; Maxillary sinus carcinoma; Radiotherapy; Surgery

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; TEGAFUR;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG FEVER; DRUG SAFETY; DYSPHAGIA; FEMALE; HUMAN; MALE; MAXILLA SINUS CARCINOMA; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; OVERALL SURVIVAL; PAIN; RADIATION DERMATITIS; RECURRENCE RISK; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; KAPLAN-MEIERS ESTIMATE; LEUCOVORIN; MALE; MAXILLARY SINUS; METHOTREXATE; MIDDLE AGED; NEOADJUVANT THERAPY; ORGAN PRESERVATION; PARANASAL SINUS NEOPLASMS; RETROSPECTIVE STUDIES; TEGAFUR; TREATMENT OUTCOME; URACIL;

EID: 68749083576     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2008.11.002     Document Type: Article

References (40)

1. Nishino H., Miyata M., Morita M., Ishikawa K., Kanazawa T., and Ichimura K. Combined therapy with conservative surgery, radiotherapy, and regional chemotherapy for maxillary sinus carcinoma. Cancer 89 (2000) 1925-1932
2. Fountzilas G., Ciuleanu E., Dafni U., Plataniotis G., Kalogera-Fountzila A., Samantas E., et al. Concomitant radiochemotherapy vs. radiotherapy alone in patients with head and neck cancer: a Hellenic Cooperative Oncology Group Phase III Study. Med Oncol 21 (2004) 95-107
3. Katori H., Tsukuda M., Mochimatsu I., Ishitoya J., Kawai S., Mikami Y., et al. Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Br J Cancer 90 (2004) 348-352
4. Seiwert T.Y., and Cohen E.E.W. State-of-the-art management of locally advanced head and neck cancer. Br J Cancer 92 (2005) 1341-1348
5. Urba S.G., Moon J., Giri P.G., Adelstein D.J., Hanna E., Yoo G.H., et al. Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial. J Clin Oncol 23 (2005) 88-95
6. Taguchi T., Tsukuda M., Mikami Y., Matsuda M., Horiuchi C., Yoshida T., et al. Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx. Acta Otolaryngol 126 (2006) 408-413
7. Sato Y., Morita M., Takahashi H., Watanabe N., and Kirikae I. Combined surgery, radiotherapy, and regional chemotherapy in carcinoma of the paranasal sinuses. Cancer 25 (1970) 571-579
8. Sakai S., Hohki A., Fuchihata H., and Tanaka Y. Multidisciplinary treatment of maxillary sinus carcinoma. Cancer 52 (1983) 1360-1364
9. Knegt P.P., Jong P.C., Andel J.G., Boer M.F., Eykenboom W., and Schans E. Carcinoma of the naal sinus. Results of a prospective pilot study. Cancer 56 (1985) 57-62
10. Katori H., Tsukuda M., and Taguchi T. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck. Cancer Chemother Pharmacol 59 (2007) 789-794
11. Grant R.N. Cancer statistics 1970. Cancer J Clin 8 (1970) 6-20
12. Le Q.T., Fu K.K., Kaplan M., Terris D.J., Fee W.E., and Goffinet D.R. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems. Cancer 86 (1999) 1700-1711
13. Hayashi T., Nonaka S., Bandoh N., Kobayashi Y., Imada M., and Harabuchi Y. Treatment outcome of maxillary sinus squamous cell carcinoma. Cancer 92 (2001) 1495-1503
14. Ozsaran Z., Yalman D., Baltalarli B., Esassolak M., and Haydaroglu A. Radiotherapy in maxillary sinus carcinomas: evaluation of 79 cases. Rhinology 41 (2003) 44-48
15. Le Q.T., Fu K.K., Kaplan M.J., Terris D.J., Fee W.E., and Goffinet D.R. Lymph node metastasis in maxillary sinus carcinoma. Int J Radiat Oncol Biol Phys 46 (1999) 541-549
16. Bhattacharyya N. Survival and staging characteristics for non-squamous cell malignancies of the maxillary sinus. Arch Otolaryngol Head Neck Surg 129 (2003) 334-337
17. Itami J., Uno T., Aruga M., and Ode S. Squamous cell carcinoma of the maxillary sinus treated with radiation therapy and conservative surgery. Cancer 82 (1998) 104-107
18. Nibu K., Sugasawa M., Asai M., Ichimura K., Mochiki M., Terahara A., et al. Results of multimodality therapy for squamous cell carcinoma of maxillary sinus. Cancer 94 (2002) 1476-1482
19. Cantu G., Bimbi G., Fabiani F., Guzzo M., Mattavelli F., Pizzi N., et al. Lymph node metastases in paranasal sinus carcinoma: prognositic value and treatment. Acta Otorhinolaryngol Ital 22 (2002) 273-279
20. Forastiere A., Koch W., Trotti A., and Sidransky D. Medical progress: head and neck cancer. N Engl J Med 345 (2001) 1890-1900
21. Vokes E.E., Weichseblaum R.R., Lippman S.M., and Hong W.K. Head and neck cancer. N Engl J Med 328 (1993) 184-194
22. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324 (1991) 1685-1690
23. Munro A.J. An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 71 (1995) 83-91
24. El-Sayed S., and Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol 14 (1996) 838-847
25. Pignon J.P., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoragional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACHNC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355 (2000) 949-955
26. Al-Sarraf M. Treatment of locally advanced head and neck cancer: historical and critical review. Cancer Control 9 (2002) 387-399
27. Posner M.R., Hershock D.M., Blajman C.R., Mickiewicz E., Winquist E., Gorbounova V., et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357 (2007) 1705-1715
28. Cadman E., Heimer R., and Davis L. Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism. Science 205 (1979) 1135-1157
29. Benz C., Schoenberg M., Choti M., and Cadman E. Schedule-dependent cytotoxicity of methotrexate and 5-fluorouracil in human colon and breast tumor cell lines. J Clin Invest 66 (1980) 1162-1165
30. Cadman E., Heimer R., and Benz C. The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells. J Biol Chem 256 (1981) 1695-1704
31. Furukawa S., Tsukuda M., Mochimatsu I., Kokatsu T., Satoh H., and Sakumoto M. Modified combination chemotherapy of cisplatin and 5-fluorouracil in squamous cell carcinomas of the head and neck. Auris Nasus Larynx 21 (1994) 181-185
32. Goepfert H., Jesse R.H., and Lindberg R. Arterial infusion and radiation therapy in the treatment of advanced cancer of the nasal cavity and paranasal sinuses. Am J Surg 126 (1973) 464-468
33. Shibuya H., Suzuki S., Horiuchi J., Takagi M., Okuyama T., Suzuki H., et al. Reappraisal of trimodal combination therapy for maxillary sinus carcinoma. Cancer 50 (1982) 2790-2794
34. Shafir M., and Raventos E. Combined multimodality (surgery, radiotherapy, intra-arterial chemotherapy) treatment of advanced carcinoma of paranasal sinuses. Recent results. Cancer Res 86 (1983) 165-168
35. Tsuji H., Kamada T., Arimoto T., Mizoe J., Shirato H., Matsuoka Y., et al. The role of radiotherapy in the management of maxillary sinus carcinoma. Cancer 57 (1986) 2261-2266
36. Lee Y.Y., Dimery I.W., Tassel P.V., Pena C.D., Blacklock J.B., and Goepfert H. Superselective intra-arterial chemotherapy of advanced paranasal sinus tumors. Arch Otolaryngol Head Neck Surg 115 (1989) 503-511
37. Katori H., Tsukuda M., and Taguchi T. Concurrent chemoradiotherapy with carboplatin and uracil-tegafur (UFT) for patients with poor performance status with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Acta Otolaryngol 127 (2007) 1099-1104
38. Cantu G., Bimbi G., Miceli R., Mariani L., Colombo S., Riccio S., et al. Lymph node metastasis in malignant tumors of the paranasal sinuses: prognostic value and treatment. Arch Otolaryngol Head Neck Surg 134 (2008) 170-177
39. Rest V.A., Chang A.W., Deschler D.G., and Lin D.T. Extent of surgery in the management of locally advanced sinonasal malignancies. Head Neck 30 (2008) 222-229
40. Nishimura G., Tsukuda M., Horiuchi C., Satake K., Yoshida T., Nagao J., et al. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas. Auris Nasus Larynx 34 (2007) 499-504